Literature DB >> 12531906

Importance of conserved Thr214 in domain A of the Na+,K+ -ATPase for stabilization of the phosphoryl transition state complex in E2P dephosphorylation.

Mads Toustrup-Jensen1, Bente Vilsen.   

Abstract

Thr(214) of the highly conserved (214)TGES sequence in domain A of the Na(+),K(+)-ATPase was replaced with alanine, and the mutant was compared functionally with the previously characterized domain A mutant Gly(263) --> Ala. Thr(214) --> Ala displayed a conspicuous 150-fold reduction of the apparent vanadate affinity for inhibition of ATPase activity, which could not simply be explained by the observed shifts of the conformational equilibria in favor of E(1) and E(1)P. The intrinsic vanadate affinity of the E(2) form and the effect on the apparent vanadate affinity of displacement of the E(1)-E(2) equilibrium were determined in a phosphorylation assay that allows the enzyme-vanadate complex to be formed under equilibrium conditions. When the E(2) form prevailed, Thr(214) --> Ala retained a reduced vanadate affinity relative to wild type, whereas the affinity of Gly(263) --> Ala became wild type-like. Thus, mutation of Thr(214) affected the intrinsic affinity of E(2) for vanadate. Furthermore, Thr(214) --> Ala showed at least a 5-fold reduced E(2)P dephosphorylation rate relative to wild type in the presence of saturating concentrations of K(+) and Mg(2+). Because vanadate is a phosphoryl transition state analog, it is proposed that defective binding of the phosphoryl transition state complex (transition state destabilization) causes the inability to catalyze E(2)P dephosphorylation properly. By contrast, the phosphorylation site in the E(1) form was unaffected in Thr(214) --> Ala. Replacement of the glutamate, Glu(216), of (214)TGES with alanine was incompatible with cell viability, indicating a very low transport activity or expression level. Our results support the hypothesis that domain A is isolated in the E(1) form, but contributes to make up the catalytic site in the E(2) and E(2)P conformations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531906     DOI: 10.1074/jbc.M212136200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Critical role of a transmembrane lysine in aminophospholipid transport by mammalian photoreceptor P4-ATPase ATP8A2.

Authors:  Jonathan A Coleman; Anna L Vestergaard; Robert S Molday; Bente Vilsen; Jens Peter Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Expression of mutant α1 Na/K-ATPase defective in conformational transition attenuates Src-mediated signal transduction.

Authors:  Qiqi Ye; Fangfang Lai; Moumita Banerjee; Qiming Duan; Zhichuan Li; Shuyi Si; Zijian Xie
Journal:  J Biol Chem       Date:  2013-01-03       Impact factor: 5.157

3.  Relationship between intracellular Na+ concentration and reduced Na+ affinity in Na+,K+-ATPase mutants causing neurological disease.

Authors:  Mads S Toustrup-Jensen; Anja P Einholm; Vivien R Schack; Hang N Nielsen; Rikke Holm; María-Jesús Sobrido; Jens P Andersen; Torben Clausen; Bente Vilsen
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

4.  A possible mechanism for low affinity of silkworm Na+/K+-ATPase for K.

Authors:  Haruo Homareda; Masahiro Otsu; Sachiko Yamamoto; Makoto Ushimaru; Sayaka Ito; Toshiyuki Fukutomi; Taeho Jo; Yoshinobu Eishi; Yukichi Hara
Journal:  J Bioenerg Biomembr       Date:  2017-10-19       Impact factor: 2.945

5.  Glutamate-183 in the conserved TGES motif of domain A of sarcoplasmic reticulum Ca2+-ATPase assists in catalysis of E2/E2P partial reactions.

Authors:  Johannes D Clausen; Bente Vilsen; David B McIntosh; Anja P Einholm; Jens Peter Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

Review 6.  Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.

Authors:  Sunil S Adav; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-11-03       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.